Clinical compound library is a collection of 3142 compounds, all of which have been permitted into the clinical trial phases. These compounds have known biological activities, low toxicity, and clear mechanism with demonstrated pre-clinical evidence.
Every compound contains detailed information on pharmacological activities, targets, clinical development status, and indications with broad spectrum covering several therapeutic areas from cancer, inflammation, infection, neuropsychiatry to cardiology, and many drug targets such as JAK, EGFR, mTOR, CDK, HDAC, AKT, PARP, etc. It is an effective tool for drug screening as well as for cell differentiation induction.
|30 μL * 10 mM (in DMSO)||15500.00|
|100 μL * 10 mM (in DMSO)||34500.00|
|250 μL * 10 mM (in DMSO)||59698.00|